Astellas Pharma agrees to buy Iveric Bio for $5.9 billion (NASDAQ:ISEE)
Zarina Lukash/iStock via Getty Images Astellas Pharma Inc. (OTCPK:ALPMF) agreed to acquire Iveric Bio (NASDAQ:ISEE) for $5.9 billion to add ...
Zarina Lukash/iStock via Getty Images Astellas Pharma Inc. (OTCPK:ALPMF) agreed to acquire Iveric Bio (NASDAQ:ISEE) for $5.9 billion to add ...
Artur PlawgoShares of Taysha Gene Therapies (NASDAQ:TSHA) have fallen by 85% since the September 2020 IPO was priced at $20. ...
Astellas Pharma Inc. (OTCPK:ALPMF) Q3 2022 Earnings Conference Call October 31, 2022 4:00 AM ET Company Representatives Kenji Yasukawa - ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.